UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000017850
Receipt No. R000020685
Official scientific title of the study Study of late renal failure evaluation by cystatin C for pediatric kidney tumor patients
Date of disclosure of the study information 2015/06/09
Last modified on 2016/06/09 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of late renal failure evaluation by cystatin C for pediatric kidney tumor patients
Title of the study (Brief title) Study of late renal failure evaluation by cystatin C for pediatric kidney tumor patients
Region
Japan

Condition
Condition kidney tumor
Classification by specialty
Pediatrics Child
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Purpose is whether serum cystatin C can be detected at an early stage renal failure in pediatric kidney tumor patients during and after treatment
Basic objectives2 Others
Basic objectives -Others examine the patients with renal failure after treatment of childhood renal tumor
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Whether the course of the subsequent renal failure of cases that showed abnormal rates of serum cystatin C.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
0 years-old <=
Age-upper limit
20 years-old >
Gender Male and Female
Key inclusion criteria Patients who participated in the clinical trial of JWiTS study
Key exclusion criteria Other than those above
Target sample size 50

Research contact person
Name of lead principal investigator Hajime Hosoi
Organization Graduate School of Medical Science
Kyoto Prefectural University of Medicine
Division name Pediatrics
Address Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JAPAN
TEL 0752515571
Email hhosoi@koto.kpu-m.ac.jp

Public contact
Name of contact person Tomoko Iehara
Organization Graduate School of Medical Science Kyoto Prefectural University of Medicine
Division name Pediatrics
Address Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JAPAN
TEL 0752515571
Homepage URL
Email iehara@koto.kpu-m.ac.jp

Sponsor
Institute JWiTS
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 09 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2011 Year 09 Month 30 Day
Anticipated trial start date
2013 Year 11 Month 16 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information practical research

Management information
Registered date
2015 Year 06 Month 09 Day
Last modified on
2016 Year 06 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020685